Literature DB >> 27872099

Conflicting Signals for Cancer Treatment.

Pierre Sujobert1,2,3,4, Alain Trautmann5,6,7,8.   

Abstract

Next-generation sequencing technologies have provided us with a precise description of the mutational burden of cancers, making it possible to identify targetable oncogene addictions. However, the emergence of resistant clones is an inevitable limitation of therapies targeting these addictions. Alternative approaches to cancer treatment are therefore required. We propose here a novel approach, based on the notion of conflicting signals and on a phenotypic description of cancer cells. "Phenotype" is an inherently complex notion that we describe in the conceptual framework of the epigenetic landscape, with a view to bridging the gap between theory and practice at the patient's bedside. By passing from theory to the description of several examples, we will illustrate how this approach can facilitate data analysis and the design of new strategies for cancer treatment. Cancer Res; 76(23); 6768-73. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27872099     DOI: 10.1158/0008-5472.CAN-16-1393

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors.

Authors:  Marion V Guerin; Fabienne Regnier; Vincent Feuillet; Lene Vimeux; Julia M Weiss; Georges Bismuth; Gregoire Altan-Bonnet; Thomas Guilbert; Maxime Thoreau; Veronica Finisguerra; Emmanuel Donnadieu; Alain Trautmann; Nadège Bercovici
Journal:  Nat Commun       Date:  2019-09-11       Impact factor: 14.919

Review 2.  Preclinical murine tumor models: a structural and functional perspective.

Authors:  Marion V Guerin; Veronica Finisguerra; Benoit J Van den Eynde; Nadege Bercovici; Alain Trautmann
Journal:  Elife       Date:  2020-01-28       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.